Evidence map›Paper›PMID 38927613›Full record

ReviewGenes2024

Contiguous Gene Syndromes and Hearing Loss: A Clinical Report of Xq21 Deletion and Comprehensive Literature Review.

Maria Teresa Bonati, Agnese Feresin, Paolo Prontera, Paola Michieletto, Valeria Gambacorta, Giampietro Ricci, Eva Orzan

Abstract readCase ReportsReview
In one paragraph

Review in Genes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Maria Teresa BonatiInstitute for Maternal and Child Health-Institute for Maternal and Child Health "Burlo Garofolo", 34137 Trieste, Italy.ORCID 0000-0001-8024-0482
Agnese FeresinIndependent Researcher, 33059 Fiumicello Villa Vicentina, Italy.ORCID 0000-0002-4187-6282
Paolo PronteraMedical Genetics Unit, S. Maria della Misericordia Hospital, 06129 Perugia, Italy.
Paola MichielettoInstitute for Maternal and Child Health-Institute for Maternal and Child Health "Burlo Garofolo", 34137 Trieste, Italy.
Valeria GambacortaDepartment of Medicine and Surgery, Section of Otorhinolaryngology, University of Perugia, 06129 Perugia, Italy.ORCID 0000-0003-4875-1201
Giampietro RicciDepartment of Medicine and Surgery, Section of Otorhinolaryngology, University of Perugia, 06129 Perugia, Italy.
Eva OrzanInstitute for Maternal and Child Health-Institute for Maternal and Child Health "Burlo Garofolo", 34137 Trieste, Italy.ORCID 0000-0001-7465-1066

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Given the crucial role of the personalized management and treatment of hearing loss (HL), etiological investigations are performed early on, and genetic analysis significantly contributes to the determination of most syndromic and nonsyndromic HL cases. Knowing hundreds of syndromic associations with HL, little comprehensive data about HL in genomic disorders due to microdeletion or microduplications of contiguous genes is available. Together with the description of a new patient with a novel 3.7 Mb deletion of the Xq21 critical locus, we propose an unreported literature review about clinical findings in patients and their family members with Xq21 deletion syndrome. We finally propose a comprehensive review of HL in contiguous gene syndromes in order to confirm the role of cytogenomic microarray analysis to investigate the etiology of unexplained HL.

Indexed as

Chromosome DeletionChromosomes, Human, XHearing LossFemaleHumansMalePedigreeSyndromecongenital hearing losscontiguous gene syndromehearing lossinner ear malformationIP3microarraymicrodeletionmicroduplicationXq21 deletion

Identifiers

PMID38927613
PMCPMC11202778

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.